New study aims to unlock personalized treatments for head and neck cancer

NCT ID NCT07190573

First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 31 times

Summary

The HOPE study is a long-term research project at Samsung Medical Center that will collect medical information and tissue/blood samples from 350 head and neck cancer patients each year. The goal is to identify biomarkers that can predict how patients will respond to treatments like immunotherapy. This study does not test a new drug but aims to improve future personalized care for this diverse cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Samsung Medical Center

    RECRUITING

    Seoul, Seoul, 06351, South Korea

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify biomarkers that help doctors choose the most effective treatments for individual head and neck cancer patients, especially in Asian populations.

What could go wrong

This is an observational study, not a treatment trial. It will not directly test a new therapy, and finding useful biomarkers is uncertain and may take years.

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.